3-iodobenzylguanidine has been researched along with Cacosmia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, J; Geibl, F; Habibi, M; Henrich, MT; Janzen, A; Librizzi, D; Luster, M; Mayer, G; Oertel, W; Sittig, E; Timmermann, L; Vadasz, D | 1 |
| Orimo, S | 1 |
| Berg, D; Postuma, RB | 1 |
| Choi, HS; Jung, YA; Kim, JS; Lee, KS; Lee, PH; Oh, YS; Park, HE; Park, IS; Ryu, DW; Song, IU; Yoo, IR | 1 |
| Mochio, S; Oka, H; Toyoda, C; Yogo, M | 1 |
| Iijima, M; Iwata, M; Kobayakawa, T; Momose, M; Osawa, M; Saito, S; Uchiyama, S | 1 |
| Alzualde, A; Bergareche, A; Gorostidi, A; Goyenechea, E; López de Munain, A; Martí Massó, JF; Moreno, F; Poza, JJ; Rodríguez, F; Ruiz-Martínez, J | 1 |
| Baba, T; Hasegawa, T; Kikuchi, A; Konno, M; Sugeno, N; Takeda, A | 1 |
| Izawa, MO; Kajimoto, Y; Kondo, T; Miwa, H | 1 |
| Becker, G; Benecke, R; Braune, S; Büttner, T; Greulich, W; Klein, W; Mark, G; Müller, A; Rieke, J; Thümler, R | 1 |
| Siderowf, A; Stern, MB | 1 |
| Kim, YJ; Lee, PH; Yeo, SH; Yong, SW | 1 |
4 review(s) available for 3-iodobenzylguanidine and Cacosmia
| Article | Year |
|---|---|
New development of diagnosis and treatment for Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Cell- and Tissue-Based Therapy; Deep Brain Stimulation; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Electric Stimulation Therapy; Genetic Therapy; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Neuroimaging; Olfaction Disorders; Parkinson Disease; Radionuclide Imaging; REM Sleep Behavior Disorder; Substantia Nigra; Ultrasonography | 2017 |
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
Early diagnosis of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Affect; Biomarkers; Handwriting; Heart; Humans; Iron; Mood Disorders; Movement Disorders; Mutation; Olfaction Disorders; Parkinson Disease; Peripheral Nervous System Diseases; Psychomotor Performance; Radiopharmaceuticals; Risk Assessment; Risk Factors; Speech; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vision, Ocular | 2002 |
Preclinical diagnosis of Parkinson's disease: are we there yet?
Topics: 3-Iodobenzylguanidine; Biomarkers; Dopamine; Genetic Testing; Humans; Mental Disorders; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Risk Assessment; Syndrome; Tomography, Emission-Computed, Single-Photon | 2006 |
8 other study(ies) available for 3-iodobenzylguanidine and Cacosmia
| Article | Year |
|---|---|
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes | 2022 |
Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Topics: 3-Iodobenzylguanidine; Aged; Cognition Disorders; Constipation; Cost of Illness; Female; Heart; Humans; Hypotension, Orthostatic; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2017 |
Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Odorants; Olfaction Disorders; Parkinson Disease; Pattern Recognition, Physiological; Physical Stimulation; Primary Dysautonomias; Radionuclide Imaging; Severity of Illness Index; Sex Factors | 2010 |
Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Autonomic Nervous System Diseases; Case-Control Studies; Chi-Square Distribution; Female; Heart; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Smell | 2010 |
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Taste | 2011 |
Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Doppler, Transcranial | 2012 |
Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Mediastinum; Middle Aged; Olfaction Disorders; Parkinson Disease, Secondary; Smell; Tomography, Emission-Computed, Single-Photon | 2007 |